跳至主要内容
临床试验/JPRN-jRCTs051230110
JPRN-jRCTs051230110招募中2 期

An exploratory clinical study to evaluate the safety and short-term nutritional outcomes of postoperative enteral nutrition with a digestive-form nutrient in patients with esophageal cancer undergoing minimally invasive esophagectomy.

Goto Hironobu0 个研究点目标入组 32 人开始时间: 2023年10月10日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 ot applicable(—)
性别
All

入选标准

  • (1) Age 18 years or older at the time of consent
  • (2) Diagnosed as cStage I/II/III (12th edition of the Esophageal Cancer Treatment Protocol) and underwent subtotal esophagectomy, primary reconstruction, enteral tube placement
  • (3) ECOG-PS 0-2
  • (4) Able to take oral intake before surgery
  • (5) Expected to undergo surgery within 60 days of study enrollment (within 60 days of completion of chemotherapy for patients undergoing preoperative chemotherapy)
  • (6) Patients are expected to be able to take oral intake for 3 months after surgery
  • (7) The patient's free written consent to participate in the study has been obtained.

排除标准

  • (1) The subject is allergic to oral nutritional supplements.
  • (2)Identified as allergic to any of the ingredients (especially soy and gelatin) in the test nutritional product, Hinex E-Gel LC.
  • (3) The subject has difficulty obtaining consent due to dementia or mental illness requiring treatment.
  • (4) The patient is taking steroids or immunosuppressive drugs due to an autoimmune disease, etc.
  • (5) Complicated viral infection requiring treatment.
  • (6) Other conditions deemed inappropriate by the Principal Investigator or Principal Investigators.

研究者

发起方
Goto Hironobu

相似试验